BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28106280)

  • 1. ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation.
    Kang BS; Hwang YJ; Dong Z
    J Cell Biochem; 2017 Aug; 118(8):2357-2370. PubMed ID: 28106280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
    Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
    Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
    Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C; Udupa KB
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Signal-Regulated Protein Kinase, c-Jun N-Terminal Protein Kinase, and Calcineurin Regulate Transient Receptor Potential M3 (TRPM3) Induced Activation of AP-1.
    Lesch A; Rössler OG; Thiel G
    J Cell Biochem; 2017 Aug; 118(8):2409-2419. PubMed ID: 28112420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
    Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
    J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of phosphorylated JNK in breast infiltrating ductal carcinoma is associated with a better overall survival.
    Yeh YT; Hou MF; Chung YF; Chen YJ; Yang SF; Chen DC; Su JH; Yuan SS
    Int J Cancer; 2006 Jun; 118(11):2678-84. PubMed ID: 16381010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
    Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
    Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2.
    Ahmed-Choudhury J; Williams KT; Young LS; Adams DH; Afford SC
    Cell Signal; 2006 Apr; 18(4):456-68. PubMed ID: 15970430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of apoptotic resistance in cadmium-induced malignant transformation: specific perturbation of JNK signal transduction pathway and associated metallothionein overexpression.
    Qu W; Fuquay R; Sakurai T; Waalkes MP
    Mol Carcinog; 2006 Aug; 45(8):561-71. PubMed ID: 16568437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK regulates the photic response of the mammalian circadian clock.
    Yoshitane H; Honma S; Imamura K; Nakajima H; Nishide SY; Ono D; Kiyota H; Shinozaki N; Matsuki H; Wada N; Doi H; Hamada T; Honma K; Fukada Y
    EMBO Rep; 2012 May; 13(5):455-61. PubMed ID: 22441692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzo (a) pyrene-induced human embryo lung cell cycle alterations through positive regulation of mitogen-activated protein kinase signal pathways].
    DU HJ; Tang N; Liu BC; Shi XL; Huang CS; Gao A; Shen FH; Ye M; You BR
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):277-80. PubMed ID: 17959047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
    Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
    Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.